Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice

Toxicologic Pathology

Volumn 32, Issue 6, 2004, Pages 710-718

  Ward, Jerrold M ^a,e   Nikolov, Nikolay P ^b   Tschetter, Jolynne R ^c   Kopp, Jeffrey B ^d   Gonzalez, Frank J ^c   Kimura, Shioko ^c   Siegel, Richard M ^b  

^a SOBRAN INC   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmune disease; CYP1B1; Glomerulonephritis; Histiocytic sarcoma; Knockout mice; Macrophages; Mice; Phagocytosis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYTOCHROME P450 1B1; DNA ANTIBODY; IMMUNOGLOBULIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME METABOLISM; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HISTIOCYTE; INCIDENCE; KIDNEY INJURY; MACROPHAGE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MONONUCLEAR PHAGOCYTE; NECROSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SARCOMA; WILD TYPE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ARYL HYDROCARBON HYDROXYLASES; DNA, SINGLE-STRANDED; FEMALE; GLOMERULONEPHRITIS; HISTIOCYTES; KIDNEY; MACROPHAGES; MALE; MICE; PHAGOCYTOSIS; SARCOMA;

ANIMALIA; GLOMERULUS;

EID: 8544225020     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490885706     Document Type: Article

References (47)

1. Baron, J. M., Zwadlo-Klarwasser, G., Jugert, F., Hamann, W., Rubben, A., Muktar, H., and Merk, H. F. (1998). Cytochrome P450 1B1: a major isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 56, 1105-10.
2. Baumann, I., Kolowos, W., Voll, R. E., Manger, B., Gaipl, U., Neuhuber, W. L., Kirchner, T., Kalden, J. R., and Herrmann, M. (2002). Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46, 191-201.
3. Berrigan, D. A., Perkins, S. N., Haines, D. C., and Hursting, S. D. (2002). Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23, 817-22.
4. Blackwell, B. N., Bucci, T. J., Hart, R. W., and Turturro, A. (1995). Longevity, body weight, and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open formula diet. Toxicol Pathol 23, 570-82.
5. Boorman, G. A., Rafferty, C. N., Ward, J. M., and Sills, R. C. (2000). Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields. Radiat Res 153, 627-36.
6. Bowes, R. C. III, Parrish, A. R., Steinberg, M. A., Willett, K. L., Zhao, W., Savas, U., Jefcoate, C. R., Safe, S. H., and Ramos, K. S. (1996). Atypical cytochrome P450 induction profiles in glomerular mesangial cells at the mRNA and enzyme level. Evdience for CYP1A1 and CYP1B1 expression and their involvement in benzo[a]pyrene metabolism. Biochem Pharmacol 52, 587-95.
7. Buters, J. T. M., Sakai, S., Richter, T., Pineau, T., Alexander, D. L., Savas, U., Doehmer, J., Ward, J. M., Jefcoate, C. R., and Gonzalez, F. J. (1999a). Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96, 1977-82.
8. Buters, J. T. M., Doehmer, J., and Gonzalez, F. J. (1999b). Cytochrome P450-null mice. Drug Metabol Reviews 31, 437-47.
9. Bynoe, M. S., Grimaldi, C. M., and Diamond, B. (2000). Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci USA 97, 2703-8.
10. Eckhaus, M. A., and Kopp, J. B. (2000). Renal Diseases in Genetically Engineered Mice. In Pathology of Genetically Engineered Mice. (J. M. Ward, J. F. Mahler, R. R. Maronpot, and J. P. Sundberg, eds.), pp. 347-364. Iowa State University Press, Ames, Iowa.
11. Eischen, C. M., Rehg, J. E., Korsmeyer, S. J., and Cleveland, J. L. (2002). Loss of bax alters tumor spectrum and tumor numbers in ARF-deficient mice. Cancer Res 62, 2184-91.
12. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. (1998). Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101, 890-8.
13. Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., and Diamond, B. (2002). Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 109, 1625-33.
14. Grimaldi, C. M., Michael, D. J., and Diamond, B. (2001). Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167, 1886-90.
15. Haines, D. C., Chattopadhyay, S., and Ward, J. M. (2001). Pathology of aging B6;129 mice. Toxicol Pathol 29, 653-61.
16. Heidel, S. M., Holston, K., Buters, J. T. M., Gonzalez, F. J., Jefcoate, C. R., and Czupyrnski, C. J. (1999). Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol Pharmacol 56, 1317-23.
17. Heidel, S. M., MacWilliams, P. S., Baird, W.M., Dashwood, W. M., Buters, J. T. M., Gonzalez, F. J., Larsen, M.C., Czuprynski, C. J., and Jefcoate, C. R. (2000). Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res 60, 3454-60.
18. Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., and Kalden, J. R. (1998). Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41, 1241-50.
19. Jennette, J. S., and Spargo, B. H. (1999). The kidney. In Pathology, 3rd ed. (E. Rubin and J. L. Farber, eds.), pp. 940-943, Lippincott-Raven, Philadelphia, PA.
20. Kakiuchi-Matsumoto, T., Isashiki, Y., Ohba, N., Kimura, K., Sonoda, S., and Unoki, K. (2001). Cytochrome P450 1B1 gene mutations in Japanese patients with primary congenital glaucoma. Am J Ophthalmol 131, 345-50.
21. Kalden, J. R. (1997). Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 6, 326-7.
22. Kopp, J. B., Klotman, M. E., Adler, S. H., Bruggeman, L. A., Dickie, P., Marines, N. J., Eckhaus, M., Bryant, J. L., Notkins, A. L., and Klotman, P. E. (1992). Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89, 1577-81.
23. Lacroix-Triki, M., Lacoste-Collin, L., Jozan, S., Charlet, J. P., Caratero, C., and Courtade, M. (2003). Histiocytic sarcoma in C57BL/6J female mice is associated with liver hematopoiesis: review of 41 cases. Toxicol Pathol 31, 403-9.
24. Libby, R. T., Smith, R. S., Savinova, O. V., Zabaleta, A., Martin, J. E., Gonzalez, F. J., and John, S. W. (2003). Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299, 1578-81.
25. Liu, Y., Cousin, J. M., Hughes, J., Van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., and Rossi, A.G. (1999). Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 162, 3639-46.
26. Lu, Q., and Lemke, G. (2001). Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293, 306-11.
27. Mandik-Nayak, L., Nayak, S., Sokol, C., Eaton-Bassiri, A., Madaio, M. P., Caton, A. J., and Erikson, J. (2000). The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immnol 12, 353-64.
28. Waf1/Cip1-deficient mice. Cancer Res 61, 6234-8.
29. McAllister, K. A., Bennett, L. M., Houle, C. D., Ward, T., Malphurs, J., Collins, N. K., Cachafeiro, C., Haseman, J., Goulding, E. H., Bunch, D., Eddy, E. M., Davis, B. J., and Wiseman, R. W. (2002). Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 62, 990-4.
30. McFadyen, M. C. E., Criuckshank, M. E., Miller, I. D., McLeod, H. L., Melvin, W. T., Haites, N. E., Parkin, D., and Murray, G. I. (2001). Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Brit J Cancer 85, 242-6.
31. Michels-Rautenstrauss, K. G., Mardin, C. Y., Zenker, M., Jordan, N., Gusek-Schneider, G. C., and Rautenstrauss, B.W. (2001). Primary congenital glaucoma: three case reports on novel mutations and combinations of mutations in the GLC3A (CYP1B1) gene. J Glaucoma 10, 354-7.
32. Murray, G. I., Melvin, W. T., Greenlee, W. F., and Burke, M. D. (2001). Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Ann. Rev Pharmacol Toxicol 41, 297-316.
33. Muskhelishvili, L., Thompson, P. A., Kusewiit, D. F., Wang, C., and Kadlubar, F. F. (2001). In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in normal human tissues. J Histochem Cytochem 49, 229-36.
34. Nebert, D. W. (1991). Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5, 1203-14.
35. Porter, D. D., Porter, H. G., and Cox, N. A. (1973). Immune complex glomerulonephritis in one-year old C57BL/6 mice induced by endogenous murine leukemia virus and erythrocyte antigens. J Immunol 111, 1626-33.
36. Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., and Matsushima, G. K. (2001). Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207-11.
37. Sharpless, N. E., Alson, S., Chan, S., Silver, D. P., Castrillon, D. H., and DePinho, R. A. (2002). p16INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res 62, 2761-5.
38. Sherr, C. J. (2004). Principles of tumor suppression. Cell 116, 235-46.
39. Shim, G. J., Kis, L. L., Warner, M., and Gustafsson, J. A. (2004). Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci USA 101, 1720-4.
40. Stoilov, I., Akarsu, A. N., and Sarfarazi, M. (1997). Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6, 641-7.
41. Tada, K., Tanaka, M., Hanayama, R., Miwa, K., Shinohara, A., Iwamatsu, A., and Nagata, S. (2003). Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1. J Immunol 171, 5718-26.
42. Vincent, A. L., Billingsley, G., Buys, Y., Levin, A. V., Priston, M., Trope, G., Williams-Lyn, D., and Heon, E. (2002). Digenic inheritance of Early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 70, 448-60.
43. Waisman, A. S., Mendlovic, S., Ruiz, P. J., Zinger, H., Meshorer, A., and Mozes, E. (1993). The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus. Int Immunol 5, 1293-1300.
44. Walport, M. J. (2000). Lupus, DNase and defective disposal of cellular debris. Nature Genet 25, 135-6.
45. Ward, J. M., Anver, M. R., Mahler, J. F., and Devor-Henneman, D. E. (2000). Pathology of mice commonly used in genetic engineering (C57BL/6; 129; B6,129; and FVB/N. In Pathology of Genetically Engineered Mice (J. M. Ward, J. F. Mahler, R. R. Maronpot, and J. P. Sundberg, eds.), pp. 161-179. Iowa State University Press, Ames, Iowa.
46. Ward, J. M., Benveniste, R. E., Fox, C. H., Battles, J. K., Gonda, M. A. and Tully, J. G. (1996). Autoimmunity in chronic active Helicobacter hepatitis of mice. Amer J Pathol 148; 509-517.
47. WuDunn, D. (2002). Genetic basis of glaucoma. Curr Opin Ophthalmol 13, 55-60; 861-917.